Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Arch Latinoam Nutr ; 53(2): 119-32, 2003 Jun.
Artigo em Espanhol | MEDLINE | ID: mdl-14528601

RESUMO

Iron is an essential micronutrient involved in multiple biochemical and physiological process. In this review we discuss the most relevant aspect of its metabolism in order to reach a better comprehension of the relevant roll that this micronutrient plays in human health.


Assuntos
Ferro/metabolismo , Micronutrientes/metabolismo , Absorção , Humanos , Ferro/farmacocinética , Micronutrientes/farmacocinética
2.
Biol Trace Elem Res ; 94(1): 73-8, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12907829

RESUMO

The iron bioavailability and acute oral toxicity in rats of a ferrous gluconate compound stabilized with glycine (SFG), designed for food fortification, was studied in this work by means of the prophylactic method and the Wilcoxon method, respectively. For the former studies, SFG was homogeneously added to a basal diet of low iron content, reaching a final iron concentration of 20.1 +/- 2.4 mg Fe/kg diet. A reference standard diet using ferrous sulfate as an iron-fortifying source (19.0 +/- 2.1 mg Fe/kg diet) and a control diet without iron additions (9.3 +/- 1.4 mg Fe/kg diet) were prepared in the laboratory in a similar way. These diets were administered to three different groups of weaning rats during 23 d as the only type of solid nourishment. The iron bioavailability of SFG was calculated as the relationship between the mass of iron incorporated into hemoglobin during the treatment and the total iron intake per animal. This parameter resulted in 36.6 +/- 6.2% for SFG, whereas a value of 35.4 +/- 8.0% was obtained for ferrous sulfate. The acute toxicological studies were performed in two groups of 70 female and 70 male Sprague-Dawley rats that were administered increasing doses of iron from SFG. The LD50 values of 1775 and 1831 mg SFG/kg body wt were obtained for female and male rats, respectively, evidencing that SFG can be considered as a safe compound from a toxicological point of view.


Assuntos
Compostos Ferrosos/metabolismo , Compostos Ferrosos/toxicidade , Alimentos Fortificados/toxicidade , Ferro/metabolismo , Animais , Disponibilidade Biológica , Feminino , Masculino , Ratos , Ratos Sprague-Dawley
3.
Biol Trace Elem Res ; 92(3): 189-212, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12794272

RESUMO

Iron plays many roles in human physiology. In this article, we summarize the basic and current knowledge of this essential micronutrient on human metabolism.


Assuntos
Ferro/metabolismo , Animais , Transporte Biológico , Células/metabolismo , Humanos , Absorção Intestinal/fisiologia , Ferro/sangue , Ferro/farmacocinética , Ferro/fisiologia , Estado Nutricional , Distribuição Tecidual
4.
J Nutr Sci Vitaminol (Tokyo) ; 48(4): 315-7, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12489824

RESUMO

Microencapsulated ferrous sulfate (SFE-171) and ferric orthophosphate in Petit-Suisse cheese were examined for iron bioavailability by the prophylactic method. The iron sources were industrially added to different samples of Petit-Suisse cheese, which were mixed with other food components in our laboratory before use. A reference standard diet inclusive of nonmicroencapsulated ferrous sulfate and a control diet low in iron content were prepared in the laboratory. The final iron content in the fortified diets was approximately 15 mg Fe/kg diet. These diets were administered to weaning rats for 23 days. The iron bioavailability was evaluated as the ratio of iron incorporated into hemoglobin to oral iron intake, thereby being estimated as 62.6 +/- 8.8% for ferrous sulfate and 59.2 +/- 10.6% for SFE-171, which were significantly effective at p < 0.01 compared to 43.4 +/- 10.5% for ferric orthophosphate. It thus turned out that SFE-171 was stable through industrial processing with Petit-Suisse cheese as the food vehicle and served as an iron fortifier equal to ferrous sulfate in bioavailability.


Assuntos
Anemia Ferropriva/prevenção & controle , Queijo , Alimentos Fortificados , Hemoglobinas/química , Ferro da Dieta/farmacocinética , Administração Oral , Animais , Disponibilidade Biológica , Queijo/análise , Composição de Medicamentos , Feminino , Compostos Férricos/farmacocinética , Compostos Ferrosos/farmacocinética , Fosfatidilcolinas/farmacocinética , Ratos , Ratos Sprague-Dawley , Desmame
5.
Food Nutr Bull ; 23(3 Suppl): 195-8, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12362794

RESUMO

We compared the absorption of BioZn, SFE-171, SO4Fe (reference standard) and SO4Zn (reference standard) alone or in combination in water and in an infant dessert. When mineral interactions were evaluated, zinc and iron were administered in a 1:1 molar relation. There 160 rats divided in 16 groups of 10 animals each which received: SO(4)65Zn, Bio65Zn, SO(4)65Zn + SO4Fe, Bio65Zn + SFE-171, SO(4)59Fe, 59SFE-171, SO(4)59Fe + SO4Zn and 59SFE-171 + BioZn either in water or an infant dessert. The results showed that BioZn has bioavailability similar to SO4Zn both in water (23.36 +/- 3.14% vs. 21.48 +/- 6.03%. respectively) and in an infant dessert (19.89 +/- 3.27% vs. 18.31 +/- 4.76%, respectively). When these zinc compounds were administered with iron no statistical difference of zinc absorption was found (Bio65Zn + SFE-171 in water 22.70 +/- 6.30%, Bio65Zn + SFE-171 in the infant dessert 18.07 +/- 5.89%, SO(4)65Zn + SO4Fe in water 24.67 +/- 5.70% and SO(4)65Zn + SO4Fe in the infant desert 20.56 +/- 5.20%). For iron, the absorption of 59SFE-171 in water was higher (p < .01) than SO(4)59Fe in water and 59SFE-171 + BioZn in water (32.35 +/- 8.32% vs. 26.27 +/- 8.83% vs. 23.69 +/- 8.37%, respectively). Iron absorption from SO(4)59Fe in water was higher (p < .01) than SO(4)59Fe + SO4Zn in water (26.27 +/- 8.83% vs. 20.21 +/- 8.72%, respectively). Iron absorption in the infant dessert was higher (p < .01) for 59SFE-171 + BioZn than SO(4)59Fe, 59SFE-171 and SO(4)59Fe + SO4Zn (22.81 +/- 6.97% vs. 16.12 +/- 6.14% vs. 16.90 +/- 6.23% vs. 15.04 +/- 6.25%, respectively). Statistical differences (p < .01) were found between iron absorption from 59SFE-171 in water and the infant dessert (32.35 +/- 8.32% vs. 16.90 +/- 6.23%, respectively) and for SO(4)59Fe (26.27 +/- 8.83% vs. 16.12 +/- 6.14% respectively). Zinc and iron interactions evaluated in a 1:1 molar relation of the minerals were observed only for iron absorption in water but not in infant dessert. No negative effect was found for zinc absorption neither in water nor in infant dessert.


Assuntos
Absorção Intestinal/efeitos dos fármacos , Ferro/farmacocinética , Zinco/farmacocinética , Animais , Interações Medicamentosas , Feminino , Análise de Alimentos , Ferro/administração & dosagem , Ferro/farmacologia , Valor Nutritivo , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Zinco/administração & dosagem , Zinco/farmacologia
6.
Nutrition ; 18(6): 510-9, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12044825

RESUMO

This review concerns the importance of zinc in growth, development, and cognitive function in children and the deleterious consequences of its deficiency on children's health. Possible strategies to overcome zinc deficiency and the results of some supplementation trials are discussed.


Assuntos
Desenvolvimento Infantil/efeitos dos fármacos , Desenvolvimento Embrionário e Fetal/efeitos dos fármacos , Crescimento/efeitos dos fármacos , Zinco/farmacologia , Zinco/fisiologia , Estatura/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Criança , Desenvolvimento Infantil/fisiologia , Pré-Escolar , Cognição/efeitos dos fármacos , Cognição/fisiologia , Desenvolvimento Embrionário e Fetal/fisiologia , Feminino , Crescimento/fisiologia , Humanos , Lactente , Lactação/metabolismo , Masculino , Gravidez , Zinco/deficiência
7.
Nutrition ; 18(3): 279-81, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11882404

RESUMO

OBJECTIVE: We investigated the iron bioavailability of microencapsulated ferrous sulfate (SFE-171) in a diet based on powdered milk by using the prophylactic method in rats. METHODS: The SFE-171 was added into fluid milk and industrially processed into powdered milk, which was then mixed in our laboratory with a normalized diet (17.2 +/- 2.1 mg Fe/kg). A reference standard diet using ferrous sulfate as iron-fortifying source (19.8 p+/- 2.9 mg Fe/kg) and a control diet without added iron (4.6 +/- 0.8 mg Fe/kg) were prepared in the laboratory in a similar way. These diets were administered to different groups of weaning rats for 28 d as the only solid nourishment. The iron bioavailability of the different sources was calculated as the relation between the mass of iron incorporated into hemoglobin during the treatment and the total iron intake per animal. RESULTS: The iron bioavailability values of SFE-171 and ferrous sulfate in the fortified diets were 41.6 +/- 6.6% and 42.6 +/- 4.2%, respectively; these results were significantly higher (P < 0.01) than the iron bioavailability of the control diet (28.8 +/- 8.1%). CONCLUSION: These results showed that iron-fortified powdered milk can be produced from fluid milk fortified with SFE-171. The bioavailability of SFE-171 in this rat model was not altered by the manufacturing process.


Assuntos
Anemia Ferropriva/prevenção & controle , Compostos Ferrosos/farmacocinética , Alimentos Fortificados/normas , Ferro da Dieta/sangue , Leite/química , Animais , Disponibilidade Biológica , Composição de Medicamentos , Feminino , Leite/metabolismo , Ratos , Ratos Sprague-Dawley , Desmame
8.
Nutr Rev ; 60(2): 52-8, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11852970

RESUMO

Food fortification is an important strategy to combat iron and zinc deficiency. This review covers the basic concepts of food fortification, as well as its advantages and disadvantages. The main characteristics of the most common zinc and iron compounds used in this procedure are also analyzed.


Assuntos
Deficiências Nutricionais/prevenção & controle , Alimentos Fortificados , Deficiências de Ferro , Zinco/deficiência , Humanos
9.
Acta bioquím. clín. latinoam ; 31(3): 283-9, sept. 1997. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-224679

RESUMO

En el presente trabajo se muestran las ventajas de la utilización de un patrón de 129I para comprobar diariamente que la respuesta del equipo de detección es constante para el 125I y poder determinar además la eficiencia para dicho nucleido. Una alternativa para conocer ese valor consiste en la aplicación de un método de coincidencia. La comparación de los resultados logrados con uno y otro método, demuestra que ambos valores de eficiencia son iguales. Por otra parte se analizan algunas cuestiones relacionadas con las ecuaciones teóricas utilizadas


Assuntos
Humanos , Espectrometria gama/métodos , Radioisótopos do Iodo/análise
10.
Acta bioquím. clín. latinoam ; 31(3): 283-9, sept. 1997. ilus, tab
Artigo em Espanhol | BINACIS | ID: bin-17168

RESUMO

En el presente trabajo se muestran las ventajas de la utilización de un patrón de 129I para comprobar diariamente que la respuesta del equipo de detección es constante para el 125I y poder determinar además la eficiencia para dicho nucleido. Una alternativa para conocer ese valor consiste en la aplicación de un método de coincidencia. La comparación de los resultados logrados con uno y otro método, demuestra que ambos valores de eficiencia son iguales. Por otra parte se analizan algunas cuestiones relacionadas con las ecuaciones teóricas utilizadas (AU)


Assuntos
Humanos , Radioisótopos do Iodo/análise , Espectrometria gama/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...